Home » Case History » ADL Farmaceutici


SETTOREPharmaceutical

ADL Farmaceutici

ADL FARMACEUTICI and USP GROUP join forces to launch a new initiative and establish ADL UNILAB

SHC Advisor assisted ADL in partner selection, deal structuring, and strategy definition

ADL Farmaceutici, supported by SHC Advisor, is developing a new international commercial strategy involving a partnership with USP Group, a global company dedicated to consumer health operating in 12 European countries, resulting in the creation of the new company ADL UNILAB. The goal of the transaction is to improve market presence and sales performance of selected product lines for both the Italian and international markets.

“We are proud to have supported ADL Farmaceutici in a highly significant strategic step. In this transaction, SHC Advisor assisted ADL Farmaceutici in defining the strategy and selecting the partner, contributing to the structuring of a solid agreement aligned with the objectives of international growth. The establishment of ADL UNILAB confirms the value of a targeted, results-oriented advisory approach.”

Matteo Alaimo, Partner, SHC Advisor